News | News By Subject | News by Disease News By Date | Search News

Allergic Rhinitis (hay fever) News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Allergy Therapeutics plc Race with Positive Phase II Data for Hayfever     5/9/2016
Nuvo Research (NRI.TO) to Discontinue all WF10 Development     12/21/2015
Adamis (ADMP) Plummets More Than 30% After FDA Rejects Its Allergy Shot Application     4/1/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
FDA Approves Merck & Co., Inc. (MRK)'s Grass Pollen Pill GRASTEK®     4/15/2014
Rigel Pharmaceuticals, Inc. (RIGL) Shares Fall After Asthma Drug Fails to Meet Phase 2 Goals; Stock Falls -13.50% at Market Close (August 26, 2013)     8/26/2013
FDA Accepts Merck & Co., Inc. (MRK)'s BLA for Investigational Allergy Immunotherapy Tablet     3/29/2013
MEDA's Dymista Approved by the FDA     5/2/2012
ISTA Pharmaceuticals, Inc. (ISTA) Reports Positive Results From Phase 2 Trial Of BEPOSONE Nasal Spray     5/1/2012
Teva Pharmaceutical Industries Limited (TEVA) Gets FDA Approval for "Dry" Allergy Aerosol QNASL     3/27/2012
Paladin Labs Inc. (CC:PLB) Announces Canadian Approval for Oralair(TM)     3/21/2012
Teva Pharmaceutical Industries Limited (TEVA) Reports Positive Phase III Findings From Late Stage Studies With QNASL Nasal Aerosol     3/5/2012
Meda AB (MEDA-A.ST): Positive Results for Dymista in Three Clinical Studies     3/5/2012

News from Around the Web
Hot Pepper Nose Spray Relieves Hay Fever     2/18/2009
New Hay Fever Vaccine From Allergy Therapeutics Ltd. Needs Just Four Shots     6/5/2008
"Good" Bacteria May Ease Hay Fever Symptoms: Institute of Food Research Study     6/3/2008
Fight Against Hay Fever and Other Allergies Helped by New Immune System Discovery     12/27/2007
'NO' Allergic Reaction Linked to Hayfever; University of the West of England Study Finds     4/3/2007
Vaccine Zaps Allergy In Record Time     2/5/2007
Once-A-Day Pill To Treat Hayfever Launced In UK     12/11/2006
Swimming In Pools May Raise Hay Fever Risk     11/27/2006
Bless you! Weekly Shots Found To Suppress Hay Fever For Years     10/5/2006
Allergy Cure Just Three Years Away     9/11/2006
Pill Could Replace Alergy Shots For Hay Fever     8/31/2006
Link Between Parkinson's And Rhinitis Revealed     8/8/2006
'Gene-Silenced' Ryegrass Cuts Out Hay Fever     8/7/2006
Indoor Swimming Pools Linked To Childhood Asthma     7/18/2006
Benadryl Edges Clarinex For Hay Fever     5/23/2006

Press Releases
Lannett (LCI) Announces Approval For Levocetirizine Dihydrochloride Oral Solution, 2.5 mg/5 mL (0.5 mg/mL)     5/16/2017
ALK-Abello A/S Release: ACARIZAX Approved In Europe For Use In Adolescent Patients With House Dust Mite-Induced Allergic Rhinitis     4/17/2017
Glenmark Pharma Reports Positive Results From A Phase III Trial Of GSP 301, Mometasone/Olopatadine Fixed-Dose Combination Nasal Spray, In Seasonal Allergic Rhinitis     3/29/2017
ASIT Biotech Reports Positive Results In Its Phase III Clinical Trial With Gp-ASIT+ For Grass Pollen Induced Allergic Rhinitis     2/28/2017
ASIT Biotech Will Publish The Results Of The Phase III Clinical Trial With Its Gp-ASIT+ Product Candidate For Treating Grass Pollen Rhinitis On 28 February, 2017     2/27/2017
Innovus Pharma To Request Regulatory Guidance For Filing For Its FlutiCare Product In Europe For The Treatment Of Allergic Rhinitis     6/3/2016
Aralez Receives Health Canada Approval For Blexten     4/25/2016
TWi Biotechnology Inc. Reports Positive Interim Results From AC-201 CR Phase 2 Proof-Of-Concept Study In Gout Patients     12/28/2015
ALK-Abello A/S Release: New Product Product (ACARIZAX) For For Treatment Of House Dust Mite Allergic Rhinitis And Asthma Obtains Reimbursement In Denmark     12/9/2015
Nuvo Research Inc. (NRI.TO) Announces 2015 Second Quarter Results     8/6/2015
InMed Forms Strategic Collaboration To Develop Novel Phytocannabinoid Therapies For Ocular Allergies     3/10/2015
MEDA: Dymista Approved In Children 6 To 11 Years Of Age With Seasonal Allergic Rhinitis     2/23/2015
Teva Pharmaceutical Industries Limited (TEVA) Announces FDA Approval Of QNASL® (Beclomethasone Dipropionate) Nasal Aerosol For Treatment Of Children With Seasonal And Perennial Allergic Rhinitis     12/19/2014
Teva Pharmaceutical Industries Limited (TEVA) Presents Positive Safety And Efficacy Data For QNASL® (Beclomethasone Dipropionate) Nasal Aerosol In Treating Children With Perennial Allergic Rhinitis     11/7/2014
ALK-Abello A/S's Partner For North America, Merck & Co., Inc. (MRK), Announces Launch Of RAGWITEK™ In Canada     5/15/2014